$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
Two Reasons to Skip Ocugen Stock Despite Some Good News
08:50pm, Wednesday, 09'th Feb 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen was one of the most explosive stocks on the market, all thanks to its coronavirus vaccine, Covaxin. But don''t rush to buy just yet. The post Two Reasons to Skip Ocugen Stock Despite Some Good News appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…
Good Penny Stocks to Invest In? 3 to Watch in 2022
05:00pm, Wednesday, 09'th Feb 2022
Are these penny stocks on your watchlist right now? The post Good Penny Stocks to Invest In?
With No Vaccine Approval, Ocugen Is the Definition of Dead Money
03:56pm, Wednesday, 09'th Feb 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Holding out hope for a Covid vaccine approval that might never come, OCGN stock is too risky while the company has no revenue. The post With No Vaccine Approval, Ocugen Is the Definition of Dead Money appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…
Two Reasons to Skip Ocugen Stock Despite Some Good News
03:50pm, Wednesday, 09'th Feb 2022
Ocugen was one of the most explosive stocks on the market, all thanks to its coronavirus vaccine, Covaxin. But don't rush to buy just yet.
2 Green Flags for Ocugen''s Future
03:30pm, Wednesday, 09'th Feb 2022 The Motley Fool
Its value has dropped substantially in recent months. Could the biotech''s fortunes change this year?
3 Biotech Stocks That Could Boom or Bust in Q1
06:00am, Tuesday, 01'st Feb 2022
The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future.
Best Penny Stocks To Buy This Week? 4 Short Squeeze Stocks To Watch
11:04am, Sunday, 30'th Jan 2022
Are short squeeze penny stocks part of your strategy this week? The post Best Penny Stocks To Buy This Week?
4 Under-the-Radar Stocks With 319% to 645% Upside in 2022, According to Wall Street
05:51am, Saturday, 29'th Jan 2022
Select analysts and investment banks believe these little-known companies can skyrocket.
Ocugen to acquire vaccine manufacturing, R&D hub in Ontario, Canada
02:37pm, Thursday, 27'th Jan 2022 Seeking Alpha
Ocugen <> to acquire manufacturing site of Liminal BioSciences in Belleville, Ontario.Amount remains undisclosed.This site would enable the company to expand its manufacturing…
Despite Big Disappointment, There's Still Potential With Ocugen Stock
04:05pm, Tuesday, 25'th Jan 2022
I would take a closer look at the rest of its pipeline before buying, but consider OCGN stock one to keep on your watchlist. The post Despite Big Disappointment, There's Still Potential With Ocugen St
7 Penny Stock Bubbles That Are Bound to Burst
10:35am, Friday, 21'st Jan 2022
Watch out with these seven penny stocks, a mix of plays that are still flying high, and a few that have already seen their bubble deflate. The post 7 Penny Stock Bubbles That Are Bound to Burst appear
Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week
09:35pm, Thursday, 20'th Jan 2022 The Motley Fool
Several factors are dragging down these vaccine stocks.
Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week
04:35pm, Thursday, 20'th Jan 2022
Several factors are dragging down these vaccine stocks.
3 Penny Stocks That Investors Are Watching Right Now And Why
01:34pm, Thursday, 20'th Jan 2022
Can these high-volume penny stocks continue to push up? The post 3 Penny Stocks That Investors Are Watching Right Now And Why appeared first on Penny Stocks to Buy, Picks, News and Information | Penny
Is Ocugen Stock a Buy Now?
10:30am, Thursday, 20'th Jan 2022
The biotech company is still looking to carve out a profitable chunk of the coronavirus vaccine market.
Sign In
Buy OCGN